126 related articles for article (PubMed ID: 29474198)
1. High Prevalence of Antithyroid Antibodies in a New Zealand Cohort of Patients With Systemic Sclerosis.
Solanki KK; Al-Majmuei M; White DHN
J Clin Rheumatol; 2018 Aug; 24(5):264-271. PubMed ID: 29474198
[TBL] [Abstract][Full Text] [Related]
2. Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis.
Kamalaksha S; White DHN; Solanki KK
Int J Rheum Dis; 2018 Jul; 21(7):1430-1435. PubMed ID: 29968328
[TBL] [Abstract][Full Text] [Related]
3. Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West India.
Singh PK; Sharma SK; Sinha A; Dutta P
Clin Rheumatol; 2016 Mar; 35(3):765-9. PubMed ID: 26861031
[TBL] [Abstract][Full Text] [Related]
4. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis.
Antonelli A; Ferri C; Fallahi P; Cazzato M; Ferrari SM; Sebastiani M; Ferrannini E
Eur J Endocrinol; 2007 Apr; 156(4):431-7. PubMed ID: 17389457
[TBL] [Abstract][Full Text] [Related]
5. Thyroid dysfunction in women with systemic sclerosis.
Marasini B; Ferrari PA; Solaro N; Selmi C
Ann N Y Acad Sci; 2007 Jun; 1108():305-11. PubMed ID: 17893994
[TBL] [Abstract][Full Text] [Related]
6. Presence of organ‑specific antibodies in patients with systemic sclerosis.
Wielosz E; Majdan M; Koszarny A; Dryglewska M; Tabarkiewicz J
Pol Arch Med Wewn; 2016 Oct; 126(11):862-869. PubMed ID: 27906879
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
Chang WS; Schollum J; White DH; Solanki KK
Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
[TBL] [Abstract][Full Text] [Related]
8. [The prevalence of thyro-peroxidase antibodies and thyroid function in Turner's syndrome].
Wikiera B; Barg E; Konieczna A; Głab E; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):190-4. PubMed ID: 17020654
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of thyroid autoantibodies and subclinical thyroid failure in relatives of patients with overt endocrine disease-associated diabetes but not type 1 diabetes alone.
Maugendre D; Massart C; Karacatsanis C; Guilhem I; Poirier JY; Sonnet E; Allannic H
Diabetes Metab; 1997 Sep; 23(4):302-7. PubMed ID: 9342543
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and characteristics of postpartum thyroid dysfunction in São Paulo, Brazil.
Barca MF; Knobel M; Tomimori E; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2000 Jul; 53(1):21-31. PubMed ID: 10931077
[TBL] [Abstract][Full Text] [Related]
11. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
12. Serological profile of patients with systemic sclerosis.
Wielosz E; Dryglewska M; Majdan M
Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
[TBL] [Abstract][Full Text] [Related]
13. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
[TBL] [Abstract][Full Text] [Related]
14. Thyroid function and prevalence of anti-thyroperoxidase (TPO) and anti-thyroglobulin (Tg) antibodies in outpatients hospital setting in an area with sufficient iodine intake: influences of age and sex.
Legakis I; Manousaki M; Detsi S; Nikita D
Acta Med Iran; 2013; 51(1):25-34. PubMed ID: 23456581
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma.
Danielides S; Mavragani CP; Katsakoulas I; Zintzaras E; Drosos AA; Vlachoyiannopoulos PG; Moutsopoulos HM
Scand J Rheumatol; 2011; 40(4):299-303. PubMed ID: 21417550
[TBL] [Abstract][Full Text] [Related]
16. [Anti-TPO antibodies and screening of thyroid dysfunction in type 1 diabetic patients].
Maugendre D; Guilhem I; Karacatsanis C; Poirier JY; Leguerrier AM; Lorcy Y; Derrien C; Sonnet E; Massart C
Ann Endocrinol (Paris); 2000 Dec; 61(6):524-530. PubMed ID: 11148327
[TBL] [Abstract][Full Text] [Related]
17. Anti-thyroid antibodies in Italian scleroderma patients: association of anti-thyroid peroxidase (anti-TPO) antibodies with HLA-DR15.
Molteni M; Barili M; Eisera N; Scrofani S; Mascagni B; Zulian C; Scorza R
Clin Exp Rheumatol; 1997; 15(5):529-34. PubMed ID: 9307861
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
[TBL] [Abstract][Full Text] [Related]
19. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.
Arora-Singh RK; Assassi S; del Junco DJ; Arnett FC; Perry M; Irfan U; Sharif R; Mattar T; Mayes MD
J Autoimmun; 2010 Aug; 35(1):52-7. PubMed ID: 20223638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
